Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

NeutriSci International Inc V.NU.H

Alternate Symbol(s):  NRXCF

NeutriSci International Inc. (NeutriSci) is a Canada-based company, which specializes in the production, and formulation of nutraceutical products within the business-to-business (B2B) industry. The Company is focused on the market development for its nutraceutical products. Its products utilize patented form of Pterostilbene called pTeroPure. pTeroPure Pterostilbene is a form of all-trans Pterostilbene that is found naturally in blueberries and is manufactured for NeutriSci by ChromaDex Corp. (ChromaDex) in the United States. NeutriSci’s neuenergy product is an energy tab designed to deliver enhanced focus and mental clarity with no sugar, no calories and no crash that is associated with energy products. It has developed proprietary IP and technology (NeutriSci IP) that creates an efficient method of bilingual absorption of nutraceuticals into the bloodstream. NeutriSci’s IP can be applied to many different categories in the beverage, food, and nutraceutical space.


TSXV:NU.H - Post by User

Comment by NEWBIE65on Aug 07, 2020 6:54pm
116 Views
Post# 31381446

RE:Kool Aid

RE:Kool Aid
We are on track for completion and shipment of the initial sample order within the next couple of days. We expect to receive an order to stock all point of sales mentioned below following product approval by the Japanese Health Ministry. Our production capacity is currently being ramped up to ensure quarterly deliveries following the initial order,” said Glen Rehman, CEO of NeutriSci.
Written product approval by the Japanese Health Ministry is on track and expected shortly. The plan is for Tabletz to be fully launched in October 2020, with planned distribution throughout 46,000 currently contracted locations in Japan. Locations and points of distribution will be announced in the coming weeks.

 BLowing smoke IMO. Approval by the japan health ministry first. 
<< Previous
Bullboard Posts
Next >>